Literature DB >> 8188173

Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.

M Ubeda1, M M Matzilevich, N M Atucha, J García-Estañ, T Quesada, S S Tang, J R Ingelfinger.   

Abstract

Activation of antinatriuretic systems such as the renin-angiotensin system, is of major importance in the pathogenesis of sodium retention in cirrhosis. In this study, we studied the intrarenal renin-angiotensin system by measuring renin and angiotensinogen mRNA expression in the kidney of rats subjected to long-term bile duct ligation in a phase before the development of ascites, when sodium retention is already present. Experiments were performed in sham-operated and bile duct-ligated rats 3 wk after surgery. Balance studies showed lower sodium excretion and greater sodium retention in the bile duct-ligated rats compared with the control animals. Plasma renin activity (4.41 +/- 1.01 ng Angiotensin I/ml/hr in the bile duct-ligated group vs. 4.20 +/- 0.74 in the controls) and plasma renin concentration were not different between the two groups. However, plasma renin substrate was significantly decreased in bile duct-ligated animals. Total kidney renin mRNA was significantly higher in the bile duct-ligated animals (0.83 +/- 0.14 densitometric units vs. 0.44 +/- 0.04 in the controls), as determined on Northern-blot analysis and densitometric quantitation. Angiotensinogen mRNA expression in the kidneys of bile duct-ligated rats was significantly decreased (0.09 +/- 0.01 densitometric units) compared with that of the controls (0.21 +/- 0.03). These results indicate that sodium-retaining, nonascitic bile duct-ligated rats show abnormalities of the intrarenal renin angiotensin system that precede changes in plasma renin activity. Our data suggest that the intrarenal renin angiotensin system may participate in the initiation of the renal pathophysiological abnormalities present in bile duct-ligated rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188173

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.

Authors:  Er-Liang Kong; Jin-Min Zhang; Ni An; Yong Tao; Wei-Feng Yu; Fei-Xiang Wu
Journal:  J Cell Commun Signal       Date:  2018-06-07       Impact factor: 5.782

2.  Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.

Authors:  A D Fialla; O B Schaffalitzky de Muckadell; P Bie; H C Thiesson
Journal:  BMC Nephrol       Date:  2018-09-19       Impact factor: 2.388

3.  Urinary Renin in Patients and Mice With Diabetic Kidney Disease.

Authors:  Jeannette Tang; Jan Wysocki; Minghao Ye; Patricia G Vallés; Johannes Rein; Mina Shirazi; Michael Bader; Roberto Ariel Gomez; Maria-Luisa S Sequeira-Lopez; Maryam Afkarian; Daniel Batlle
Journal:  Hypertension       Date:  2019-05-13       Impact factor: 10.190

4.  Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.

Authors:  F Wong; P Liu; L Blendis
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.